Role of transglutaminase 1 in stabilisation of intercellular junctions of the vascular endothelium

Werner Baumgartner, Nikola Golenhofen, Agnes Weth, Takashi Hiiragi, Rob Saint, Martin Griffin, Detlev Drenckhahn

Research output: Contribution to journalArticle

Abstract

Microvascular endothelial monolayers from mouse myocardium (MyEnd) cultured for up to 5 days postconfluency became increasingly resistant to various barrier-compromising stimuli such as low extracellular Ca2+ and treatment with the Ca2+ ionophore A23187 and with the actin depolymerising compound cytochalasin D. In contrast, microvascular endothelial monolayers from mouse lung microvessels (PulmEnd) remained sensitive to these conditions during the entire culture period which corresponds to the well-known in vivo sensitivity of the lung microvasculature to Ca2+depletion and cytochalasin D treatment. One molecular difference between pulmonary and myocardial endothelial cells was found to be transglutaminase 1 (TGase1) which is strongly expressed in myocardial endothelial cells but is absent from pulmonary endothelial cells. Resistance of MyEnd cells to barrier-breaking conditions correlated strongly with translocation of TGase1 to intercellular junctions. Simultaneous inhibition of intracellular and extracellular TGase activity by monodansylcadaverine (MDC) strongly weakened barrier properties of MyEnd monolayers, whereas inhibition of extracellular TGases by the membrane-impermeable active site-directed TGase inhibitor R281 did not reduce barrier properties. Weakening of barrier properties could be also induced in MyEnd cells by downregulation of TGase1 expression using RNAi-based gene silencing. These findings suggest that crosslinking activity of intracellular TGase1 at intercellular junctions may play a role in controlling barrier properties of endothelial monolayers.

Original languageEnglish
Pages (from-to)17-25
Number of pages9
JournalHistochemistry and Cell Biology
Volume122
Issue number1
Early online date25 Jun 2004
DOIs
Publication statusPublished - Jul 2004

Fingerprint

Intercellular Junctions
Vascular Endothelium
Cytochalasin D
Lung
Endothelial Cells
Microvessels
Ionophores
Calcimycin
Gene Silencing
RNA Interference
Actins
Catalytic Domain
Myocardium
Down-Regulation
Membranes
transglutaminase 1

Keywords

  • VE-cadherin
  • permeability
  • cell adhesion
  • TGaseK
  • TGase1
  • RNAi

Cite this

Baumgartner, Werner ; Golenhofen, Nikola ; Weth, Agnes ; Hiiragi, Takashi ; Saint, Rob ; Griffin, Martin ; Drenckhahn, Detlev. / Role of transglutaminase 1 in stabilisation of intercellular junctions of the vascular endothelium. In: Histochemistry and Cell Biology. 2004 ; Vol. 122, No. 1. pp. 17-25.
@article{38f5d81423b249eda090ccb276643f85,
title = "Role of transglutaminase 1 in stabilisation of intercellular junctions of the vascular endothelium",
abstract = "Microvascular endothelial monolayers from mouse myocardium (MyEnd) cultured for up to 5 days postconfluency became increasingly resistant to various barrier-compromising stimuli such as low extracellular Ca2+ and treatment with the Ca2+ ionophore A23187 and with the actin depolymerising compound cytochalasin D. In contrast, microvascular endothelial monolayers from mouse lung microvessels (PulmEnd) remained sensitive to these conditions during the entire culture period which corresponds to the well-known in vivo sensitivity of the lung microvasculature to Ca2+depletion and cytochalasin D treatment. One molecular difference between pulmonary and myocardial endothelial cells was found to be transglutaminase 1 (TGase1) which is strongly expressed in myocardial endothelial cells but is absent from pulmonary endothelial cells. Resistance of MyEnd cells to barrier-breaking conditions correlated strongly with translocation of TGase1 to intercellular junctions. Simultaneous inhibition of intracellular and extracellular TGase activity by monodansylcadaverine (MDC) strongly weakened barrier properties of MyEnd monolayers, whereas inhibition of extracellular TGases by the membrane-impermeable active site-directed TGase inhibitor R281 did not reduce barrier properties. Weakening of barrier properties could be also induced in MyEnd cells by downregulation of TGase1 expression using RNAi-based gene silencing. These findings suggest that crosslinking activity of intracellular TGase1 at intercellular junctions may play a role in controlling barrier properties of endothelial monolayers.",
keywords = "VE-cadherin, permeability, cell adhesion, TGaseK, TGase1, RNAi",
author = "Werner Baumgartner and Nikola Golenhofen and Agnes Weth and Takashi Hiiragi and Rob Saint and Martin Griffin and Detlev Drenckhahn",
year = "2004",
month = "7",
doi = "10.1007/s00418-004-0668-y",
language = "English",
volume = "122",
pages = "17--25",
journal = "Histochemistry and Cell Biology",
issn = "0948-6143",
publisher = "Springer",
number = "1",

}

Role of transglutaminase 1 in stabilisation of intercellular junctions of the vascular endothelium. / Baumgartner, Werner; Golenhofen, Nikola; Weth, Agnes; Hiiragi, Takashi; Saint, Rob; Griffin, Martin; Drenckhahn, Detlev.

In: Histochemistry and Cell Biology, Vol. 122, No. 1, 07.2004, p. 17-25.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Role of transglutaminase 1 in stabilisation of intercellular junctions of the vascular endothelium

AU - Baumgartner, Werner

AU - Golenhofen, Nikola

AU - Weth, Agnes

AU - Hiiragi, Takashi

AU - Saint, Rob

AU - Griffin, Martin

AU - Drenckhahn, Detlev

PY - 2004/7

Y1 - 2004/7

N2 - Microvascular endothelial monolayers from mouse myocardium (MyEnd) cultured for up to 5 days postconfluency became increasingly resistant to various barrier-compromising stimuli such as low extracellular Ca2+ and treatment with the Ca2+ ionophore A23187 and with the actin depolymerising compound cytochalasin D. In contrast, microvascular endothelial monolayers from mouse lung microvessels (PulmEnd) remained sensitive to these conditions during the entire culture period which corresponds to the well-known in vivo sensitivity of the lung microvasculature to Ca2+depletion and cytochalasin D treatment. One molecular difference between pulmonary and myocardial endothelial cells was found to be transglutaminase 1 (TGase1) which is strongly expressed in myocardial endothelial cells but is absent from pulmonary endothelial cells. Resistance of MyEnd cells to barrier-breaking conditions correlated strongly with translocation of TGase1 to intercellular junctions. Simultaneous inhibition of intracellular and extracellular TGase activity by monodansylcadaverine (MDC) strongly weakened barrier properties of MyEnd monolayers, whereas inhibition of extracellular TGases by the membrane-impermeable active site-directed TGase inhibitor R281 did not reduce barrier properties. Weakening of barrier properties could be also induced in MyEnd cells by downregulation of TGase1 expression using RNAi-based gene silencing. These findings suggest that crosslinking activity of intracellular TGase1 at intercellular junctions may play a role in controlling barrier properties of endothelial monolayers.

AB - Microvascular endothelial monolayers from mouse myocardium (MyEnd) cultured for up to 5 days postconfluency became increasingly resistant to various barrier-compromising stimuli such as low extracellular Ca2+ and treatment with the Ca2+ ionophore A23187 and with the actin depolymerising compound cytochalasin D. In contrast, microvascular endothelial monolayers from mouse lung microvessels (PulmEnd) remained sensitive to these conditions during the entire culture period which corresponds to the well-known in vivo sensitivity of the lung microvasculature to Ca2+depletion and cytochalasin D treatment. One molecular difference between pulmonary and myocardial endothelial cells was found to be transglutaminase 1 (TGase1) which is strongly expressed in myocardial endothelial cells but is absent from pulmonary endothelial cells. Resistance of MyEnd cells to barrier-breaking conditions correlated strongly with translocation of TGase1 to intercellular junctions. Simultaneous inhibition of intracellular and extracellular TGase activity by monodansylcadaverine (MDC) strongly weakened barrier properties of MyEnd monolayers, whereas inhibition of extracellular TGases by the membrane-impermeable active site-directed TGase inhibitor R281 did not reduce barrier properties. Weakening of barrier properties could be also induced in MyEnd cells by downregulation of TGase1 expression using RNAi-based gene silencing. These findings suggest that crosslinking activity of intracellular TGase1 at intercellular junctions may play a role in controlling barrier properties of endothelial monolayers.

KW - VE-cadherin

KW - permeability

KW - cell adhesion

KW - TGaseK

KW - TGase1

KW - RNAi

UR - http://www.scopus.com/inward/record.url?scp=4043162778&partnerID=8YFLogxK

UR - http://link.springer.com/article/10.1007%2Fs00418-004-0668-y

U2 - 10.1007/s00418-004-0668-y

DO - 10.1007/s00418-004-0668-y

M3 - Article

C2 - 15221408

VL - 122

SP - 17

EP - 25

JO - Histochemistry and Cell Biology

JF - Histochemistry and Cell Biology

SN - 0948-6143

IS - 1

ER -